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Several studies have implicated the aquaporins (aqp) 1, 4, and 9 in the pathogenesis of malignant brain tumours, suggesting
that they contribute to motility, invasiveness, and oedema formation and facilitate metabolism in tumour cells under hypoxic
conditions. We have studied the expression of aqp1, 4, and 9 in biopsies from glioblastomas, isolated tumour stem cells grown
in a tumoursphere assay and analyzed the progenitor and diﬀerentiated cells from these cultures. We have compared these to
the situation in normal rat brain, its stem cells, and diﬀerentiated cells derived thereof. In short, qPCR in tumour tissue showed
presence of aqp1, 4, and 9. In the tumour progenitor population, aqp9 was markedly more highly expressed, whilst in tumour-
derived diﬀerentiated cells, aqp4 was downregulated. However, immunostaining did not reveal increased protein expression
of aqp9 in the tumourspheres containing progenitor cells; in contrast, its expression (both mRNA and protein) was high in
diﬀerentiated cultures. We, therefore, propose that aquaporin 9 may have a central role in the tumorigenesis of glioblastoma.
1.Introduction
Since Peter Agres’ discovery of the ﬁrst water channel in 1992
[1],another12aquaporinshavebeendescribedandlinkedto
several diseases. Mainly, the aquaporin water channel family
is divided into aquaporins and aquaglyceroporins as either
exclusive water channels or water channels that also facilitate
the transport of other solutes, reviewed by Borgnia et al. [2].
Gliomas are the most common primary brain tumours [3].
Due to their invasive and aggressive nature, this diagnosis
bears a poor prognosis with a median survival of only one
year from the time of diagnosis [4]. As for many other cancer
types, an increasing body of evidence points to stem cells
being culprits of tumour formation [5–9].
During recent years, several studies have shown that the
aquaporins 1 and 4 [10–22] and the aquaglyceroporin 9 [17,
22–25] are overexpressed in tumours such as glioblastomas
comparedtonormalbraintissue.Thismay,therefore,endow
them with several of the characteristics of malignant brain
tumours. For instance, aqp1 may play a role in their invasive-
ness [14] and in providing water inﬂux into the expanding
cellular protrusions. Also, tumour cells from astrocytomas
and glioblastomas thrive under hypoxic conditions [26].
In this setting, aqp9 expression may account for their
resistance to hypoxic and ischemic conditions, by facilitating
clearance of lactate [27]a n dg l y c e r o l[ 28] resulting from
hypoxia and cellular damage, respectively [29, 30]. It might,
therefore, play a role in both the energy metabolism of
normal brain tissue and provide increased tolerance for
hypoxia under pathological conditions. Oedema formation
is a major contributor to the morbidity and mortality asso-
ciated with malignant brain tumours. Aqp4 is widespread
throughout the brain parenchyma but especially enriched in
glial cells neighbouring the ventricles, subarachnoid spaces,
and blood vessels [31, 32]. This channel is polarized into
the perivascular astrocytic end-feet processes together with
the inward rectifying potassium channel Kir4.1 [33]. An
aqp4-knockout model of water intoxication showed reduced
oedema formation [34].
Using gene transfection to create knock-in and knockout
experiments, these three aquaporins have been clearly impli-
cated in cell motility [35–38]. Water permeability linked to
F-actin stability in membrane leading edges and ﬁlopodia
extension are suggested mechanisms. There is, therefore,2 The Scientiﬁc World Journal
an obvious implication for the migration of various cancer
cell types.
In this study, we investigated the expression and localiza-
tion of aquaporin 1, 4, and 9 in glioblastoma biopsies and in
the tumour stem cells propagated as tumourspheres as well
as diﬀerentiated cells isolated from these tumours. Rat tissue
and cultured cells were used for comparison as indicators of
the normal situation in the absence of human-derived tissue.
2.MaterialsandMethods
2.1. Tissue. Tumour tissue was obtained from brain tumour
resections of glioblastomas performed at the Department of
Neurosurgery at the University of Oslo, Faculty divisions
of Rikshospitalet and Ullev˚ al University Hospitals. The
histopathological diagnosis and grade was established by
neuropathologists according to the WHO classiﬁcation [39].
Six patients were included in the study. Tissue harvesting was
approvedbytheNorwegianNationalCommitteeforMedical
Research Ethics.
For all experiments with rodent neural stem cells, Wistar
rats were used. The animals were of both sexes and from the
age of four weeks and older. The animals were housed under
conditions in accordance with the local Animal Research
Committee. The animals were anaesthetized by inhalation
of isoﬂurane as indicated by the manufacturer and rapidly
decapitated.
2.2. Cell Culture. Rat tissue was harvested from the
area of the lateral wall of the lateral ventricle in the
forebrain/cerebrum. All brain tissue was transported in
Leibovitz-15 medium (L-15) (BioWhittaker/Cambrex) on
iceandprocessedaspreviouslydescribed[40].Thetissuewas
then mechanically dissociated with scissors and submitted to
enzymatic treatment with either 0.5mg/mL or 1x trypsin-
EDTA (BioWhittaker/Cambrex) for human tumour tissue
and cells, and 13.2U/mL papain (Worthington) for rat tissue
andcells.Finally,thesuspensionwasﬁlteredthrougha70μm
strainer (Falcon) and seeded at 400000 viable cells/10mL
medium as indicated by the trypan blue exclusion method.
The cells were cultivated as spheres in 25mL ﬂasks (NUNC)
with DMEM/F12 (Invitrogen) in the presence of 20ng/mL
epidermal growth factor (EGF, R&D Inc., Minneapolis,
Minn, USA), 10ng/mL basic ﬁbroblast growth factor (bFGF,
R&D Inc.), 20μL/mL B-27 without vitamin A (Invitrogen),
10mM Hepes, 10μL/mL Pen/Strep, and 2.5μg/mL heparin
(LEO Pharma, Oslo, Norway). They were fed twice weekly.
The spheres were cultured for ﬁve to seven days until reach-
ing approximately 100μm in diameter, then enzymatically
dissociated and reseeded. Dissociated cells from spheres were
diﬀerentiated at 100000cells/dish on 40mm glass-bottom
dishes (Willco Wells BV, Amsterdam, The Netherlands) or
4-well slides (NUNC International) coated with 15μg/mL
poly-L-ornithine (Sigma, St. Louis, Mo, USA). DMEM/F12
medium was augmented with fetal calf serum (3.75%; PAA
Laboratories, Pasching, Austria) and 25μL/mL B-27 with
vitamin A (Invitrogen), 1μg/mL laminin and 10μL/mL of
Pen/Strep. All cultures were kept in an incubator at 5%-6%
CO2, pH 7.2–7.4.
2.3. Immunocytochemistry
2.3.1. Preparation of Sections from Neurospheres and Cell
Culture Dishes. For ﬁxation of neurospheres, a few mL
of medium was transferred to a 15mL tube. The neuro-
spheres were allowed to sink to the bottom of the tube
by gravitation or easy centrifugation. Spheres were ﬁxed in
4% paraformaldehyde, before being cryoprotected in 20%
sucrose in PBS. Spheres were then frozen at −70◦C, before
being sectioned by cryotome at 10μm. Cell cultures were
ﬁxed with 4% paraformaldehyde for 30min, followed by
2 ×5min rinsing with PBS. The cells were incubated for one
hourwithasolutionconsistingof1%Bovineserumalbumin
(BSA), 0.01% NaN3, 0.1% Triton-X100 diluted in PBS.
Primary antibodies were incubated overnight at 4◦C, rinsed
in PBS, and incubated with secondary antibodies for 1 hour
at 4◦C in PBS containing 1% BSA and 0.3% Triton X-100
(Sigma-Aldrich). Control experiments were (1) no primary
antibody, secondary antibody only to determine nonspeciﬁc
binding of secondary antibody and (2) no antibody to
determine the level of any autoﬂuorescence. Analysis and
image acquisition was done on an Olympus BV 61 FluoView
confocal microscope (Olympus, Hamburg, Germany), using
the FV10-ASW 1.7 software (Olympus).
2.3.2. Antibodies. The following primary antibodies were
used: antiaquaporin 1 (rabbit polyclonal 1:500, Abcam
ab15080), antiaquaporin 4 (rabbit aﬃnity puriﬁed poly-
clonal 1μg/mL, Chemicon International), antiaquaporin 9
(rabbit polyclonal 5μg/mL, Alpha Diagnostic) (both latter
aquaporin antibodies a kind gift from O. P. Ottersen),
anti-HuNestin (mouse IgG1 1:1000, R&D Systems), anti-
Sox2 (rabbit aﬃnity puriﬁed polyclonal antibody 1:200,
Chemicon International), anti-Doublecortin (DCX, goat
aﬃnity puriﬁed polyclonal 1:100, Santa Cruz Biotechnol-
ogy, Inc.), anti-TuJ1 (rabbit aﬃnity puriﬁed polyclonal anti-
body 1:1000, Sigma), and anti-GFAP (mouse monoclonal
1:1000, R&D Systems). Hoechst (nr. 33342 Sigma) was used
for counterstaining of the nucleus. Secondary antibodies
against the appropriate species used were labelled either with
Alexa Fluor 488 (1:500, Molecular Probes), or Cy3 (1:1000,
Jackson ImmunoResearch Laboratories).
2.4. Reverse Transcription and Quantitative Polymerase Chain
Reaction (q-PCR). Tissue samples from normal SVZ and
tumour were harvested in RNAlater TissueProtect tubes
(Qiagen). A portion of the cells from the sphere cultures
was harvested by centrifugation and RNA isolated 24h after
passage. The remaining spheres were further cultivated and
diﬀerentiated for 7 days before RNA isolation. Total RNA
from tissue and cells was then isolated directly by using QIA-
zol (Qiagen, Germany) and the RNeasy Mini Kit (Qiagen,
Germany) according to the manufacturer’s protocol. The
concentration of each RNA sample was determined by using
the Nanodrop spectrophotometer and analyzed for quality
visually with agarose gel electrophoresis.
Quantitative PCR was done using the standard curve
method. Samples and standards (serial dilutions of total
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and random hexamer priming (50uL reaction volume, Taq-
Man Reverse Transcription Reagents from Applied Biosys-
tems). Quantitative real-time PCR (qPCR) of each cDNA
sample were run in triplicates using the TaqMan PCR Core
Reagent Kit and the ABI Prism 7900 Sequence Detection
System and software (Applied Biosystems, Foster City, Calif,
USA) according to the manufacturer’s instructions. The
TaqMan aquaporin 1, 4, and 9 primers and detection
probes were bought from Applied Biosystems. Primer sets
for human aquaporins were AQP1: Hs00166067-m1, AQP4:
Hs00242342-m1, and AQP9: Hs00175573-m1. Primer sets
for rat aquaporins were AQP1: Rn01410034-m1, AQP4:
Rn00563196-m1, and AQP9: Rn01530733-m1. For endoge-
nous control reactions, 18S rRNA (TaqMan rRNA control
reagents, Applied Biosystems) was used. The data acquired
were analyzed with the Sequence Detector software (version
1.6.3, Applied Biosystems). Gene expression was presented
relative to the levels of 18S ribosomal RNA.
2.5. Preparation of Protein Extract and Western Analysis.
Spheres were harvested, pelleted at 600×gf o r1 0 m i na t
4◦C and washed in PBS. Adherent diﬀerentiated cells were
washedinPBS,scraped,andpelletedasdescribedabove.The
cells were homogenized using an eppendorf hand homog-
enizer in 0.3M sucrose, 0.1M NaPi, pH 7.4, 1mM EDTA
and protease inhibitors (Complete; Roche, Mannheim, Ger-
many). The homogenates were centrifuged at 1,000×gf o r
15min,andthesupernatantswerecollected.Sodiumdodecyl
sulphate (SDS) was added to the supernatants to a ﬁnal
concentrationof0.1%,incubatedfor30minat4◦Cfollowing
centrifugation at 23,000×gf o r3 0 m i na t4 ◦C[ 41]. The
supernatants from each sample containing cytosolic as well
as membrane proteins were collected, and the amount of
total protein was determined using the DC Protein Assay
(Bio-Rad Laboratories, Hercules, Calif, USA). 10μg of whole
protein extracts were loaded onto a 12% Nu-PAGE gel
(Invitrogen) and subsequently blotted onto a 0.2μmP V D F
membrane. The membrane was blocked with 5% skimmed
milk in PBS/0.1% Tween 20 (PBST) and probed with rabbit
α-human aquaporin 9 (1/1500, 85910, AbCam) or mouse
α-human GAPDH (1/4000, Sigma) in TBST and 5% BSA.
Secondary antibody was HRP-conjugated antirabbit IgG
(1/5000 in 0.5% skimmed milk in TBST) or antimouse IgG
(1/50000 in 0.5% skimmed milk in TBST), respectively. The
blots were developed using Super Signal West Dura ECL
substrate (Pierce), detected by Kodak Molecular Imaging
System (Kodak MI, version 5.0) and quantitated using the
ImageQuant TL software (Amersham Biotech).
2.6. Statistics. The results were presented as a mean ± S.E.M.
Diﬀerencesweretestedwithunpairedtwo-sampledStudent’s
t-test and considered signiﬁcant when P<0.05.
3. Results
We examined the mRNA gene expression of aqp1, 4, and
9i nt h ea d u l tr a tS V Za n dp r i m a r yt u m o u r so fh u m a n
glioblastoma. Besides tissue, we also studied progenitor
cells from free-ﬂoating neurospheres and cells of one week
diﬀerentiation to reveal any changes associated with matu-
ration. This analysis was accompanied by an assessment of
expression at protein level using immunoﬂuorescence and in
the case of aqp9 with Western blot as well.
3.1. Aquaporin mRNA Expression in Rat Tissues and Cells
(Table 1). In normal rat brain tissue, aqp9 was the highest
expressed water channel, with a lesser amount of aqp4.
The aquaporin/18S-ratio was estimated as 5.23 ± 0.32 and
3.98 ± 0.76, respectively (mean ± SEM, n = 4). Only small
amounts of aqp1 were found (1.00 ± 0.83) in rat brain. Both
neuralprogenitoranddiﬀerentiatedcellsexpressedstrikingly
higher levels of aqp1 than normal brain tissue. The highest
level was in progenitors and was expressed at a much higher
level than the other aquaporins. The individual results in
this group were, however, highly scattered, and many of the
progenitoranddiﬀerentiatedcellcultureshadlowexpression
of aquaporin (Figure 1).
Also, we found signiﬁcant upregulation of aqp4 in the
diﬀerentiated cells compared to the rat neural progenitor
population (Figure 1(a)). Aqp4 was very lowly expressed
among the progenitor cells (0.04 ± 0.01), but diﬀerentiated
cells displayed aqp4/18S ratio of 5.20 ± 3.01 (mean ± SEM,
n = 8).Inthecaseofaqp9progenitor,anddiﬀerentiatedcells
werecalculatedat0.3±0.2and1.70±1.06,respectively(mean
± SEM, n = 4 (progenitor) and n = 7( d i ﬀerentiated)).
3.2. Aqp9 Is Highly Expressed in the Progenitor Cells from
Tumour. In tumour tissue, aqp4 expression was the most
abundant (6.75 ± 2.8 6 ) ,b u tt h e r ew a sn e a r l ya sm u c ha q p 9
(5.37 ± 4.62) (mean ± SEM, n = 6, relative to aqp1 set
to 1). When comparing the expression of aquaporin 9 by
the tumour stem cells to that obtained directly from tissue,
aqp9 was increased with respect to tissue, while aqp 1 and
4 were decreased (Figure 1(b)). Among the tumour stem
cells, aqp9/18S was measured to 19.9 ± 6.35, whereas similar
r a t i o sf o ra q p 1a n d4w e r el e s s ,0 .02 ± 0.01 and 0.04 ± 0.18,
respectively (mean ± SEM, n = 7, relative to aqp1 expression
in tumour set to 1).
3.3.DistinctiveBehaviourofAqp9. Normalexpressionexhib-
ited by rat progenitors and diﬀerentiated derivatives can
be compared to that of tumour stem cells and deriva-
tives (Figure 2). Whilst aqp4 expression does not markedly
increase from tumour progenitor to diﬀerentiated cell, its
expression does increase markedly in rat diﬀerentiated cells.
The situation for aqp9 is clearly diﬀerent. Aqp9 is highly
increased in both tumour progenitor and diﬀerentiated
derivativeswhencomparedtonormalrattissue-derivedcells.
3.4. Diﬀerentiated Tumour Cells Show Extensive Labeling
for Aqp4 and 9. The PCR experiments were supplemented
with immunostaining of the aquaporins and other cellular
markers to reveal their distribution among the diﬀerent
cell types. Tumourspheres were sectioned and stained and
showed extensive labeling for the immature markers Nestin
and Sox2. They were also positive for the glial marker GFAP
which might reﬂect a more diﬀerentiated cell compartment
in the sphere. However, few spheres were found positive for4 The Scientiﬁc World Journal
Table 1: Relative mRNA expression of Aquaporins 1, 4, and 9 in normal rat brain and human brain tumour-derived tissue, stem cells, and
diﬀerentiated cells. Values are based on setting the ratio of Aqp1/18S in tissue to 1.
Rat Tumour
Mean value SEM Mean value SEM
Aqp1 Tissue 0.999999 0.824987 1 0.348343
Aqp4 Tissue 3.979995 0.763569 6.75893 2.862152
Aqp9 Tissue 5.23405 0.320761 5.375927 4.025013
Aqp1 Spheres 3.641413 1.945498 0.016193 0.007146
Aqp4 Spheres 0.039853 0.005692 0.424486 0.179481
Aqp9 Spheres 0.306192 0.162423 19.903079 11.36836
Aqp1 Diﬀerentiated 5.330058 4.272465 0.006569 0.002806
Aqp4 Diﬀerentiated 5.527011 3.008557 0.493593 0.190121
Aqp9 Diﬀerentiated 1.706198 1.062908 9.1752 6.359034
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Figure 1: q-PCR analysis of mRNA expression of aquaporins 1, 4, and 9 in rat versus glioblastoma. (a) Levels of aquaporins in rat tissues.
Progenitors mainly express aqp1. Diﬀerentiated cells expressed all three with aqp9 expressed the least. ∗values that diﬀer statistically using
unpaired two-sampled Student’s t-test and considered signiﬁcant when P<0.05. (b) Levels of aquaporins in tumour tissues. In the
progenitor and diﬀerentiated cell populations, aqp9 was conspicuously dominant compared to aqp1 and 4. ∗values that diﬀer statistically
using unpaired two-sampled Student’s t-test and considered signiﬁcant when P<0.05.
aqp4 and aqp9. These showed at most a rather week immun-
ostaining (Figures 3(a), 3(b) and 3(c)). In contrast, many
tumoursphere cells were positive for aqp1 (Figure 3(d)).
Tumour stem cells from glioblastoma diﬀerentiated into
cells expressing mature neuronal and glial markers, TuJ1
and GFAP, respectively. Yet, they retained their expression
of the immature marker nestin. The cells displayed aber-
rant morphology, with multiple atypical nuclei. Cells were
immunopositive for aquaporins 1, 4, and 9. These aquapor-
ins appeared widely distributed throughout cells—perhaps
cytoplasms and membranes (Figures 4(a)–4(c) and 4(f)).
Although there was no signiﬁcant increase in the mRNA
expression of aqp4 and 9 in diﬀerentiation of progenitor
cells, the diﬀerentiated cells exhibited extensive labelling of
aqp4 and 9 proteins compared to progenitor cells. Control
experiments indicated no nonspeciﬁc staining of secondary
antibodies or autoﬂuorescence.
AW e s t e r nb l o te x p e r i m e n t( Figure 5) assessed protein
levels of expression of aqp9 to be robust in both progenitors
and diﬀerentiated cells suggesting that the immunolabeling
experiments indicate diﬀerential accessibility, and, therefore,
of location of antigen in sphere cells (Figure 4(c)).
4. Discussion
All three aquaporins were expressed in the rat brain tissue,
and this was the situation too in human tumour tissue
though aqp1 was lowest in both situations. In rat stemThe Scientiﬁc World Journal 5
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Figure 2: Distinctive behaviour of aqp9. Normal expression exhibited by rat progenitors and diﬀerentiated derivatives can be compared
to that of tumour stem cells and derivatives. Whilst aqp4 expression does not markedly increase from tumour progenitor to diﬀerentiated
cell, its expression increases markedly in rat diﬀerentiated cells. The situation for aqp9 is clearly diﬀerent. Aqp9 is highly increased in both
progenitor and diﬀerentiated derivatives when compared to normal rat tissue-derived cells.
(a) (b) (c)
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Figure 3: Expression of some proteins in tumourspheres. Tumourspheres from glioblastoma were mainly negative for the aquaporins 4 and
9 but were positive for immature and glial markers. (a, b) A few tumourspheres were weakly positive for aqp4 (a, red) but most were negative
(b). (c) Few sphere cells were found to express aqp9. (d) Many sphere cells expressed aqp1. (e) A sphere showing the immature markers
nestin (green) and Sox2 (red). (f) A sphere stained for nestin (green) and GFAP (red). Scale bars: (a, b, d, and e) 20μm; (c) 50μm.6 The Scientiﬁc World Journal
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Figure 4: Diﬀerentiated cells. Tumour stem cells from glioblastoma diﬀerentiate into cells expressing aquaporins 1, 4, and 9 in addition
to mature neuronal and glial markers. Yet, they retain their expression of immature markers. The cells displayed obviously aberrant
morphology; note the multiple nuclei. (a, b): Diﬀerentiated cells of both glial and neuronal morphology stained positively for aqp4 (green).
(c) Cells also exhibited extensive positive signal for aqp9 (red). (d) Nestin positive cells (green). (e) Cells positive for TuJ1 (red) and GFAP
(green) Some cells display labelling with both antigens (green and red, together). (f) Most diﬀerentiated cells were positive for aqp1 (red).
Scale bars: 20μm.
GAPDH
Spheres Differentiated
31 kD
40 kD
Aqp9
Figure 5: Western blot showing Aquaporin 9 protein expression
in tumour progenitor cells (spheres) and cells diﬀerentiated from
them. 100μg of protein was loaded in each lane.
cells, aqp1 dominated, but all three were again expressed
in diﬀerentiated cells. However, in the tumour stem cells
and diﬀerentiated cells, only aqp9 dominated. This was,
therefore, in stark contrast to the situation for normal brain
(as evidenced in tissue and cells derived from rat). The
immunoﬂuorescence studies indicated that protein levels of
aqp4and9werelowintumourprogenitors(tumourspheres)
and highly expressed in the diﬀerentiated cells arising from
them. As there seemed to be an inconsistency of expression
of aqp9 at message level compared to immunolabeling
of protein in the case of tumour progenitors, we carried
out Western blot experiments of proteins extracted from
progenitors and diﬀerentiated cells. These showed that
although protein expression appeared lower in progenitors,
it was still substantial if levels of the housekeeping gene
GAPDH were compared. Thus, there would seem to be a
diﬀerence in location within the cell or state of processing
of aqp9 protein that inhibits detection by immunolabeling of
intact (though permeablised) cells.
In rat tissue, the low expression of aqp1 and substantially
greateraqp4-expressionwereasexpected,sinceaqp4isfound
in abundance in astrocytes throughout the brain, while aqp1
appears only in the choroid plexus [42, 43]. However, the
high expression level of aqp9 was somewhat more surprising
but could be explained by expression in cells lining the
ventricles [44]. Interestingly, none of the studies by Badaut
et al. [29, 30] have shown labelling of the ependymal layer,
butratherwhatseemstobeasubependymallayer,andmight
represent the neurogenic subventricular zone (SVZ) [29].
This might correspond to our distinctive ﬁnding of a highThe Scientiﬁc World Journal 7
expression of aqp9 in the stem cells from tumour, as further
discussed below. Nevertheless, through mechanical isolation
of the SVZ, there will inevitably be included both ependymal
and subependymal material, which is very thin and tightly
adherent to the underlying SVZ [45].
Due to the diﬀerence in species and diﬀerent PCR probes
for aquaporins in rat and human, human tumour can, of
course, only be quantitatively compared to normal human
tissue. And although we have not performed PCR analysis
of normal adult human brain, we would have expected
to ﬁnd, but did not compared to rat, an increase for all
three channels, as tumour tissue has exhibited profoundly
increased immunohistochemical labeling in comparisons
between normal and tumour brain tissue. The upregulation
has been supported at protein level by immunoblot [10, 13–
17, 26, 46].
Both aqp4 and 9 expression in tumour tissue appears
robust. A common MAP kinase pathway is found to be
involved in the regulation of both aqp4 and 9 channels under
hypoxic conditions [47]. Another study has found evidence
for regulation through protein kinase C for both aqp4 and 9
[48]. This may imply that these two aquaporins at least share
some pathways of regulation in common.
Although we have not performed immunocytochemistry
on diﬀerentiated cells from normal human brain, the
diﬀerentiated tumour cells clearly diﬀered from their normal
counterparts found in brain tissue according to published
data. Normal astrocytes display a polarized distribution of
the aqp4 in brain tissue [31], as this is found only on
perivascular end feet, together with the inward rectifying
K+-channel 4.1 [25, 49, 50]. Together, they enable directed
water ﬂow. It has been shown in several studies that in
various pathological conditions like injury [51], ischemia
[52], subarachnoid haemorrhage, SAH [47]a n db r a i n
tumour [53–55], polarization is lost, rendering aqp 4 highly
distributed throughout the entire cell. This is similar to the
labellingdistributionwefoundindiﬀerentiatedtumourstem
cells but as in vitro conditions obviously diﬀer greatly from
those of in vivo, further experimental evaluation is required.
One possible explanation for this might be downreg-
ulation or dysfunction of the anchoring proteins for the
aquaporins. In a study by Warth et al. [23], polarization of
aqp4 was totally dependent on its binding through the agrin
protein for linking to the dystrophin complex, a cell-surface
receptor that links the cytoskeleton to the extracellular
matrix [56]. Agrin is, on the other hand, an extracellular
heparin sulphate proteoglycan and is previously shown to
be downregulated in glioblastoma [57]. In another study,
Warth et al. [17] found that this phenomenon is a function
of malignancy, as high-grade tumours showed a highly
exaggerated and randomly distributed aquaporin 4 channel
towards the entire cell membrane. Agrin is also linked to the
vascular endothelial membrane and upon downregulation
causesseveraltightjunctionproteinstodisappear,disrupting
the blood brain barrier [58]. The agrin protein might,
therefore, be central for the development of brain oedema,
acting in concert with other proteins like aqp4 and tight
junction proteins.
Does Aqp9 Exhibit a Special Role for the Tumorigenicity
of Tumour Stem Cells? When comparing the expression of
aquaporin 9 among the progenitor cells to that obtained
directly from tissue, aqp9 is increased with respect to
tissue, while aqp1 and 4 are decreased. Aqp9 is many times
more highly expressed by tumour stem cells and their
diﬀerentiated progeny than is the case in normal rat-derived
cells. Furthermore, the high level of aqp9 transcription
detected in the tumour-derived progenitor cells not evident
yet at protein level—we show that it is lowly expressed using
immunoﬂuorescent staining and moderately expressed as
assessed for cell lysates using Western blot—is a prelude for
high expression of both mRNA and protein of this gene in
the “diﬀerentiated” cells arising from them. This implies a
central role for aqp9 in the progenitor cell population in
glioblastoma. Aquaporin 9 is also found in the cytoplasms
and cell processes of astrocytes [53] but does not display the
universal preference for pericapillary astrocytic membranes
as is the case for aqp4 [59].
The marked upregulation of aqp9 mRNA in tumour
stem cells (grown in culture as neurospheres) followed
by high expression at both message and protein level in
“diﬀerentiated” cultures growing adherently in vitro implies
a role for this water channel in the life process of the tumour.
Perhaps ability of migrating tumour stem cells to colonise
surrounding normal tissue is somehow advantaged by the
expression of aqp9 water channel as some of the cells acquire
am o r e“ d i ﬀerentiated” phenotype.
If these proteins play a role in the tumorigenicity of
tumour stem cells, the aquaporins, aqp9 in particular, may
be candidates for targeted immunotherapy, as at least their
extracellular epitopes should be accessible for antibodies.
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